protocol

[키워드] 1:1 absolute reduction addition Administered Admission adverse event adverse events all-cause mortality allocation Arm ARMS assigned assumed baseline Bia breast-feeding China clinical Combination Compliance conducted Confirmed COVID-19 infection Contamination COVID-19 COVID-19 infection Date detect dissemination dose ECG element eligible end point enrolled enrolment evaluate evaluate the effect excluded Follow-up frontline healthcare worker greater HCQ HCW HCWs Health personnel healthcare hospital Hospitalization hospitals Hydroxychloroquine ICU India Infection infection rate initiated intensive care Intervention intervention arm invasive ventilation investigator Italy Laboratory Loading dose medication MONITOR Non-invasive number objective Open-label organ support outcome parallel group participant Patient performed Personal protective equipment PPE pregnant Prevent prevention of COVID-19 Primary outcome proportion protocol provided QT prolongation QTc randomisation randomised randomised controlled trial randomization Randomized controlled trial rate of infection readmission receive reduction Registered registry renal replacement therapy reported Research Sample size Secondary outcomes secure Standard Statistical power status stratified Study protocol Treatment Trial two-sided Vasopressor website
[DOI] 10.1186/s13063-020-04679-3 PMC 바로가기 [Article Type] Letter